Chemoinformaics analysis of 9-Hydroxyoctadecanoic acid
| Molecular Weight | 300.483 | nRot | 16 |
| Heavy Atom Molecular Weight | 264.195 | nRig | 7 |
| Exact Molecular Weight | 300.266 | nRing | 0 |
| Solubility: LogS | -3.01 | nHRing | 0 |
| Solubility: LogP | 3.244 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 57 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 56.4705 |
| nHD | 2 | BPOL | 36.9835 |
| QED | 0.686 |
| Synth | 2.01 |
| Natural Product Likeliness | 0.164 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -4.307 |
| MDCK | 0.0000375 |
| BBB | 0.98 |
| PPB | 0.688011 |
| VDSS | 1.893 |
| FU | 0.276932 |
| CYP1A2-inh | 0.967 |
| CYP1A2-sub | 0.364 |
| CYP2c19-inh | 0.915 |
| CYP2c19-sub | 0.364 |
| CYP2c9-inh | 0.52 |
| CYP2c9-sub | 0.218 |
| CYP2d6-inh | 0.047 |
| CYP2d6-sub | 0.176 |
| CYP3a4-inh | 0.058 |
| CYP3a4-sub | 0.462 |
| CL | 11.715 |
| T12 | 0.659 |
| hERG | 0.077 |
| Ames | 0.061 |
| ROA | 0.059 |
| SkinSen | 0.372 |
| Carcinogencity | 0.213 |
| EI | 0.971 |
| Respiratory | 0.196 |
| NR-Aromatase | 0.009 |
| Antiviral | Yes |
| Prediction | 0.551529 |